人类表皮生长因子和受体细胞外域综合体的晶体结构
Hideo Ogiso1, Ryuichiro Ishitani, Osamu Nureki
1RIKEN Genomic Sciences Center, 1-7-22 Suehiro-cho, Tsurumi, 230-0045, Yokohama, Kanagawa, Japan.
Cell
|September 26, 2002
概括
表皮生长因子 (EGF) 与其受体 (EGFR) 结合,触发细胞生长. 这项研究揭示了EGF-EGFR复合体的晶体结构,详细介绍了细胞信号传递所必需的独特受体二分化机制.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 结构生物学 结构生物学
背景情况:
- 表皮生长因子 (EGF) 是细胞增殖和分化的关键调节者.
- EGF通过与表皮生长因子受体 (EGFR) 的细胞外区域结合来发挥其功能,EGFR是一种受体氨酸激酶.
- EGFR激活涉及受体二分化,这是下游信号传输的关键步骤.
研究的目的:
- 为了确定人类EGF和EGFR细胞外区域复合物的晶体结构.
- 为了阐明EGF介导EGFR二分化的分子机制.
主要方法:
- 采用X射线晶体学,以3.3 Å分辨率确定2:2 EGF-EGFR复合物的结构.
- 进行EGFR的突变,以验证观察到的二分化接口.
主要成果:
- 晶体结构显示了EGFR I-III域的C形排列,EGF在域I和III之间对接.
- 确定了一种独特的"受体介导二分化"机制,其中一个EGFR分子的域II的β-hairpin臂与另一个分子的身体相互作用.
- EGFR突变发生证实了这种受体-受体相互作用在二分化中的关键作用.
结论:
- 该研究为EGF-EGFR相互作用和二元化提供了高分辨率的结构基础.
- 鉴定到的"受体介导的二分化"是一种对EGFR激活至关重要的新机制.
- 这些发现增强了我们对EGFR信号通路的理解,并可能为针对癌症的治疗策略提供信息.
相关概念视频
Internal Receptors
57.4K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
57.4K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Integrins
4.8K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
4.8K
Anchoring Junctions
4.3K
Anchoring junctions are multiprotein complexes that help cells connect to other cells and the extracellular matrix. Anchoring junctions are present on the lateral and basal surfaces of cells, providing strong and flexible connections. Focal adhesions are often formed due to cell interactions with the ECM substrata, which initiate signal transduction via kinase cascades and other mechanisms. Together, they provide stability and tissue integrity. There are three types of anchoring junctions:...
4.3K
Immunoglobulin-like Cell Adhesion Molecules
3.3K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.3K
Transducer Mechanism: Enzyme-Linked Receptors
4.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.4K


